Regulation 6
SCHEDULE 5N.I.Qualifying test
1. A test is a qualifying test if—N.I.
(a)it is a test for the detection of coronavirus undertaken using a device which the manufacturer states has—
(i)a sensitivity of at least 80%,
(ii)a specificity of at least 97%, and
(iii)a limit of detection of less than or equal to 100,000 SARS-CoV-2 copies per millilitre,
(b)it is not a test provided or administered under the National Health Service Act 2006, the National Health Service (Wales) Act 2006, the National Health Service (Scotland) Act 1978 or the Health and Personal Social Services (Northern Ireland) Order 1972, and
(c)the test sample is taken from the person no more than [F1two] days before—
(i)in the case of that person travelling to Northern Ireland on a commercial transport [F2service that—
(aa)does not involve the person transiting through a country or territory outside the common travel area, the service’s scheduled time of departure;
(bb)involves the person transiting through a country or territory outside the common travel area, the scheduled time of departure of the first part of the service], or
(ii)in any other case, the actual time of departure of the vehicle, vessel or aircraft on which that person is travelling to the common travel area.
Textual Amendments
F1Word in Sch. 5 para. 1(c) substituted (7.12.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 11) Regulations (Northern Ireland) 2021 (S.R. 2021/323), regs. 1(2), 7(a)(i) (with reg. 1(3))
F2Sch. 5 para. 1(c)(i)(aa)(bb) substituted for words (7.12.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel, Operator Liability and Information to Passengers) (Amendment No. 11) Regulations (Northern Ireland) 2021 (S.R. 2021/323), regs. 1(2), 7(a)(ii) (with reg. 1(3))
[F31A. For the purposes of paragraph 1, a person transits through a country or territory if they arrive in that country or territory for the sole purpose of continuing a journey to Northern Ireland—N.I.
(a)on a conveyance other than the conveyance on which they arrived, or
(b)on the same conveyance, having temporarily disembarked from it.]
Textual Amendments
2. For the purposes of paragraph 1—N.I.
“sensitivity”, in relation to a device, means how often the device correctly generates a positive result;
“specificity”, in relation to a device, means how often the device correctly generates a negative device.
3. Notification of a negative rest result must include, in English, French or Spanish, the following information—N.I.
(a)the name of the person from whom the sample was taken,
(b)that person's date of birth,
(c)the negative result of the test,
(d)the date the test sample was collected or received by the test provider,
(e)the name of the test provider and information sufficient to contact that provider,
(f)a statement—
(i)that the test was a polymerase chain reaction test, or
(ii)of the name of the device that was used for the test.